NCT04278768 2026-03-19Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)Curis, Inc.Phase 1/2 Suspended366 enrolled
NCT04485052 2023-10-23Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid LeukemiaInnovent Biologics (Suzhou) Co. Ltd.Phase 1/2 Suspended222 enrolled